We are thrilled to share that Segmed has successfully raised a $10.4 million Series A funding round, spearheaded by iGan Partners and Advocate Health, with contributions from Castellan Group, LLC, Engine Health Capital, Bold Brain Capital, Fox Chase Cancer Center, and existing investors including Y Combinator, Nina Capital, Nova Capital, Blumberg Capital, and Expeditions Fund. The current Series A round follows a financing by Flashpoint Venture Capital received in 2023. This oversubscribed round signifies a major milestone in Segmed’s mission to revolutionize medical imaging solutions for AI development and real-world evidence.
Category
🤖
Tech